Le compte de cet utilisateur a été supprimé
Moore Tyler
 |
Selective hair loss inhibition of type II alpha-reductase was demonstrated in all treated patients. This study shows that finasteride causes inhibition of alpha-reductase no prescription pharmacy online activity in human BPH tissue with selectivity for the type II isozyme. Of these, 27 men aged 55-80 hair loss y (median 69 y) completed the study, including 18 patients on treatment. Epithelial proliferation was, however, greater in prostatic tissue with histological manifestation of inflammation (2.02% vs 0.89%, P 0.001). Epithelial proliferation oral contraceptive brands was examined quantitatively in the resected tissue using MIB-1 antibody to Ki-67 finasteride tablets and counting the percentage of positively staining cells. Thirty-one patients presenting with attestive bladder outflow obstruction were prospectively randomized to receive either finasteride or placebo (2:1) for 24 weeks. In spite of this, no significant effects in epithelial proliferation or tissue morphology were demonstrated. Type II alpha-reductase activity was strongly does propecia work inhibited by finasteride in resected BPH tissue, with over 100-fold decrease in V(max) (P 0.001), whereas the type I isozyme was inhibited 5-fold (P 0.005). This prospective, controlled, randomized study finasteride drug examines various relationships between changes in tissue alpha-reductase isozyme activity, epithelial proliferative index and morphology in men with BPH treated with finasteride medication finasteride for 6 months, and correlates these with clinical response. Its therapeutic efficacy is believed to be mediated through selective inhibition of prostatic alpha-reductase (type II). Symptom score determination, uroflow and prostate volume were assessed at baseline and end of study. No significant difference in epithelial proliferation was observed between the finasteride and placebo groups. Improvement in uroflow and reduction in prostatic volume in patients treated with finasteride did not reach statistical significance. The presence of inflammation was, however, associated with significantly greater proliferative activity. A prospective randomized trial evaluating tissue effects of finasteride therapy in benign prostatic hyperplasia.Finasteride is widely used for the treatment of benign prostatic hyperplasia (BPH). The power of this study was austere by the small number of recruited patients, and a larger study would be required for further investigation of morphological changes induced by finasteride in BPH tissue and their biochemical basis.. Prostatic tissue was obtained by ultrasound-guided needle biopsy at baseline and by transurethral resection (TURP) at end of study for biochemical and morphometric analysis. Positive correlation between the total epithelial volume and the ratio of transition zone volume/total prostate volume was observed in the placebo group (r 0.834), whereas there was no such correlation in men taking finasteride (r -0.300), consistent with a reduction in epithelial content in the treatment group.
|